Response to Editor: Commentary on "Influence of Tumor Cavitation on Assessing the Clinical Benefit of Anti-PD1 or PD-L1 Inhibitors in Advanced Lung Squamous Cell Carcinoma".

Clin Lung Cancer

Department of Thoracic Oncology, Tianjin Lung Cancer Center, Tianjin Cancer Institute & Hospital, Tianjin Medical University, Tianjin, China; Tianjin Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin Cancer Institute & Hospital, Tianjin Medical Un

Published: December 2024


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2024.08.013DOI Listing

Publication Analysis

Top Keywords

response editor
4
editor commentary
4
commentary "influence
4
"influence tumor
4
tumor cavitation
4
cavitation assessing
4
assessing clinical
4
clinical benefit
4
benefit anti-pd1
4
anti-pd1 pd-l1
4

Similar Publications

Background: Lumbar spinal stenosis (LSS) is common in adults with achondroplasia and predisposes individuals to neurogenic claudication. It remains unverified whether the severity of stenosis in patients with achondroplasia is associated with clinical outcomes. Similarly, the role of sagittal balance parameters in clinical outcomes has not been determined.

View Article and Find Full Text PDF

Background: Peripheral nerve injury commonly results in pain and long-term disability for patients. Recovery after in-continuity stretch or crush injury remains inherently unpredictable. However, surgical intervention yields the most favorable outcomes when performed shortly after injury.

View Article and Find Full Text PDF

This Letter to the Editor responds to the recent publication by Patel et al. (J Robot Surg. Jul 11;19(1):370, 2025), which outlines a framework and recommendations for telesurgery.

View Article and Find Full Text PDF

Background: Bone marrow (BM) Measurable Residual Disease (MRD) assessments underestimate disease burden in multiple myeloma, as focal lesions can exist outside the marrow. Functional imaging, like positron emission tomography-computed tomography (PET-CT), offers valuable insights into residual disease beyond the marrow. Combining marrow flow cytometry (FCM) with PET-CT for a composite MRD (cMRD) assessment before and after autologous stem cell transplant (ASCT) is expected to provide prognostic information, particularly in settings where patients receive extended duration of anti-myeloma therapy prior to ASCT.

View Article and Find Full Text PDF